VIR · ISSUER CIK 1706431
Vir Biotechnology, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Vir Biotechnology, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202613:34 | Oct 27, 2026 | VIR | Director | A · Grant | — | +12,731 | 12,731 | New | — | ||
| Aug 12, 202614:30 | Aug 11, 2026 | VIR | Director | J · Other | — | −8,000 | 40,656 | -16% | — | ||
| Aug 12, 202614:30 | Aug 11, 2026 | VIR | Director | J · Other | — | +8,000 | 517,917 | +2% | — |